BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seré KM, Rosing J, Hackeng TM. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance. Blood 2004;104:3624-30. [PMID: 15292065 DOI: 10.1182/blood-2004-03-1146] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Peraramelli S, Thomassen S, Heinzmann A, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M, Rosing J. Role of exosite binding modulators in the inhibition of Fxa by TFPI. Thromb Haemost 2018;115:580-90. [DOI: 10.1160/th15-04-0354] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
2 Chattopadhyay R, Sengupta T, Majumder R. Inhibition of Intrinsic Xase by Protein S: A Novel Regulatory Role of Protein S Independent of Activated Protein C. ATVB 2012;32:2387-93. [DOI: 10.1161/atvbaha.112.250928] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
3 Heeb MJ, Radtke KP, Fernández JA, Tonnu L. Plasma contains protein S monomers and multimers with similar direct anticoagulant activity. J Thromb Haemost 2006;4:2215-22. [PMID: 16824189 DOI: 10.1111/j.1538-7836.2006.02117.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hackeng TM, Seré KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A 2006;103:3106-11. [PMID: 16488980 DOI: 10.1073/pnas.0504240103] [Cited by in Crossref: 210] [Cited by in F6Publishing: 171] [Article Influence: 14.0] [Reference Citation Analysis]
5 Peraramelli S, Suylen DP, Rosing J, Hackeng TM. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa. Thromb Haemost. 2012;108:266-276. [PMID: 22627666 DOI: 10.1160/TH11-12-0902] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Seré KM, Willems GM, Rosing J, Hackeng TM. Protein S multimers are generated in vitro and affect protein S structure-function analyses. Semin Hematol 2006;43:S111-20. [PMID: 16427377 DOI: 10.1053/j.seminhematol.2005.11.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
7 Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Meijers JC, Porte RJ, Lisman T. Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels. Br J Haematol. 2013;162:819-826. [PMID: 23841464 DOI: 10.1111/bjh.12462] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
8 Preston RJ, Ajzner E, Razzari C, Karageorgi S, Dua S, Dahlbäck B, Lane DA. Multifunctional specificity of the protein C/activated protein C Gla domain. J Biol Chem 2006;281:28850-7. [PMID: 16867987 DOI: 10.1074/jbc.M604966200] [Cited by in Crossref: 86] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
9 Buil A, Trégouët DA, Souto JC, Saut N, Germain M, Rotival M, Tiret L, Cambien F, Lathrop M, Zeller T. C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Blood. 2010;115:4644-4650. [PMID: 20212171 DOI: 10.1182/blood-2010-01-263038] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
10 Dockal M, Hartmann R, Fries M, Thomassen MC, Heinzmann A, Ehrlich H, Rosing J, Osterkamp F, Polakowski T, Reineke U, Griessner A, Brandstetter H, Scheiflinger F. Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI). J Biol Chem 2014;289:1732-41. [PMID: 24275667 DOI: 10.1074/jbc.M113.533836] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
11 Perrin J, Depasse F, Lecompte T, De Raucourt E, Planche V, Ajzenberg N, Ollivier V, Helley D, Dignat-georges F, Morange P, Drouet L, Samama † M, Minon J, Freyburger G, Mingant F, Sinegre T, Dutrillaux F, Marlu R, Jeanpierre E, Dargaud Y, Sauguet P, Gris J, Duchemin J, Hezard N, Gueret P, Le Cam-duchez V, Tardy B, Delahousse B, Perrin J, Ravanat C, Hanss M, Fontana P, Feugeas O, Gheldof D, Douxfils J. Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma. Thrombosis Research 2015;136:125-30. [DOI: 10.1016/j.thromres.2014.12.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
12 Brinkman HJM, Ahnström J, Castoldi E, Dahlbäck B, Marlar RA. Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH. J Thromb Haemost 2021;19:281-6. [PMID: 33405384 DOI: 10.1111/jth.15108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Parsi K, Exner T, Low J, Dang Fung Ma D, Joseph J. In vitro Effects of Detergent Sclerosants on Antithrombotic Mechanisms. European Journal of Vascular and Endovascular Surgery 2009;38:220-8. [DOI: 10.1016/j.ejvs.2009.03.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
14 Hackeng TM, Maurissen LFA, Castoldi E, Rosing J. Regulation of TFPI function by protein S. Journal of Thrombosis and Haemostasis 2009;7:165-8. [DOI: 10.1111/j.1538-7836.2009.03363.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
15 Winckers K, Ten Cate-hoek AJ, Beekers KCMM, Erkens P, Hamulyák K, Ten Cate H, Hackeng TM. Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis: Letters to the Editor. Journal of Thrombosis and Haemostasis 2012;10:2208-11. [DOI: 10.1111/j.1538-7836.2012.04884.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Maurissen LFA, Castoldi E, Simioni P, Rosing J, Hackeng TM. Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals. Journal of Thrombosis and Haemostasis 2010;8:750-8. [DOI: 10.1111/j.1538-7836.2010.03743.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
17 Peraramelli S, Thomassen S, Heinzmann A, Rosing J, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs. J Thromb Haemost 2014;12:1826-37. [PMID: 25163770 DOI: 10.1111/jth.12713] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
18 Rodriguez-Rius A, Lopez S, Martinez-Perez A, Souto JC, Soria JM. Identification of a Plasma MicroRNA Profile Associated With Venous Thrombosis. Arterioscler Thromb Vasc Biol 2020;40:1392-9. [PMID: 32160777 DOI: 10.1161/ATVBAHA.120.314092] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
19 Somajo S, Koshiar RL, Norström E, Dahlbäck B. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C. Thromb Res 2014;134:144-52. [PMID: 24835672 DOI: 10.1016/j.thromres.2014.04.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
20 Castoldi E, Simioni P, Tormene D, Thomassen MC, Spiezia L, Gavasso S, Rosing J. Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. J Thromb Haemost 2007;5:971-9. [PMID: 17461930 DOI: 10.1111/j.1538-7836.2007.02448.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
21 Maurissen LFA, Thomassen MCLGD, Nicolaes GAF, Dahlbäck B, Tans G, Rosing J, Hackeng TM. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood 2008;111:3034-41. [DOI: 10.1182/blood-2007-06-089987] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
22 van Veen JJ, Gatt A, Makris M. Thrombin generation testing in routine clinical practice: are we there yet? Br J Haematol. 2008;142:889-903. [PMID: 18564356 DOI: 10.1111/j.1365-2141.2008.07267.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 123] [Article Influence: 11.2] [Reference Citation Analysis]
23 Preston RJ, Tran S, Johnson JA, Ní Áinle F, Harmon S, White B, Smith OP, Jenkins PV, Dahlbäck B, O'Donnell JS. Platelet factor 4 impairs the anticoagulant activity of activated protein C. J Biol Chem 2009;284:5869-75. [PMID: 19129181 DOI: 10.1074/jbc.M804703200] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
24 Alshaikh NA, Rosing J, Thomassen MCLGD, Castoldi E, Simioni P, Hackeng TM. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma. J Thromb Haemost 2017;15:950-60. [DOI: 10.1111/jth.13657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
25 Alhenc-Gelas M, Canonico M, Morange PE, Emmerich J; Geht Genetic Thrombophilia Group. Protein S inherited qualitative deficiency: novel mutations and phenotypic influence. J Thromb Haemost 2010;8:2718-26. [PMID: 20880255 DOI: 10.1111/j.1538-7836.2010.04073.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
26 van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, Makris M. Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A. Thrombosis Research 2009;123:895-901. [DOI: 10.1016/j.thromres.2008.09.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
27 Castoldi E, Hackeng TM. Regulation of coagulation by protein S: . Current Opinion in Hematology 2008;15:529-36. [DOI: 10.1097/moh.0b013e328309ec97] [Cited by in Crossref: 89] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
28 Tardy-Poncet B, Piot M, Brunet D, Chapelle C, Bonardel M, Mismetti P, Morange P, Tardy B. TFPI resistance related to inherited or acquired protein S deficiency. Thromb Res 2012;130:925-8. [PMID: 23079294 DOI: 10.1016/j.thromres.2012.07.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Andersson HM, Arantes MJ, Crawley JT, Luken BM, Tran S, Dahlbäck B, Lane DA, Rezende SM. Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain. Blood 2010;115:4878-85. [PMID: 20308596 DOI: 10.1182/blood-2009-11-256610] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
30 Hackeng TM, Rosing J. Protein S as cofactor for TFPI. Arterioscler Thromb Vasc Biol 2009;29:2015-20. [PMID: 19661488 DOI: 10.1161/ATVBAHA.108.177436] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
31 Ndonwi M, Broze G. Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa–tissue factor. J Thromb Haemost 2008;6:1044-6. [DOI: 10.1111/j.1538-7836.2008.02980.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
32 Wosiewicz P, Żorniak M, Hartleb M, Barański K, Hartleb M, Onyszczuk M, Pilch-Kowalczyk J, Kyrcz-Krzemień S. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability. Clin Res Hepatol Gastroenterol 2016;40:722-9. [PMID: 27160816 DOI: 10.1016/j.clinre.2016.03.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
33 Broze GJ, Girard TJ. Tissue factor pathway inhibitor: structure-function. Front Biosci (Landmark Ed). 2012;17:262-280. [PMID: 22201743 DOI: 10.2741/3926] [Cited by in Crossref: 91] [Cited by in F6Publishing: 73] [Article Influence: 10.1] [Reference Citation Analysis]
34 Dienava-verdoold I, Marchetti MR, te Boome LCJ, Russo L, Falanga A, Koene HR, Mertens K, Brinkman HJM. Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies. Thromb Haemost 2017;107:468-76. [DOI: 10.1160/th11-07-0457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
35 Thomassen MC, Heinzmann AC, Herfs L, Hartmann R, Dockal M, Scheiflinger F, Hackeng TM, Rosing J. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α. J Thromb Haemost 2015;13:92-100. [PMID: 25348176 DOI: 10.1111/jth.12766] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
36 Van de Vijver P, Schmitt M, Suylen D, Scheer L, Thomassen MCLGD, Schurgers LJ, Griffin JH, Koenen RR, Hackeng TM. Incorporation of Disulfide Containing Protein Modules into Multivalent Antigenic Conjugates: Generation of Antibodies against the Thrombin-Sensitive Region of Murine Protein S. J Am Chem Soc 2012;134:19318-21. [DOI: 10.1021/ja306993t] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
37 Maroney SA, Hansen KG, Mast AE. Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor. Curr Opin Hematol 2013;20:403-9. [PMID: 23839295 DOI: 10.1097/MOH.0b013e3283634412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
38 van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, Makris M. The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents. Int J Lab Hematol 2009;31:189-98. [PMID: 18190585 DOI: 10.1111/j.1751-553X.2007.01022.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
39 Coll E, Robles-Carrillo L, Reyes E, Francis JL, Amirkhosravi A. Assessment of protein C anticoagulant pathway by thrombin generation assay in the presence of endothelial cells. J Thromb Haemost 2013;11:1916-9. [PMID: 23848340 DOI: 10.1111/jth.12353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
40 Peraramelli S, Rosing J, Hackeng TM. TFPI-dependent activities of Protein S. Thrombosis Research 2012;129:S23-6. [DOI: 10.1016/j.thromres.2012.02.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
41 Westhoff CL, Pike MC, Cremers S, Eisenberger A, Thomassen S, Rosing J. Endogenous thrombin potential changes during the first cycle of oral contraceptive use. Contraception 2017;95:456-63. [PMID: 28088496 DOI: 10.1016/j.contraception.2017.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Horne MK, Merryman PK, Cullinane AM, Nghiem K, Alexander HR. The impact of major surgery on blood coagulation factors and thrombin generation. Am J Hematol 2007;82:815-20. [DOI: 10.1002/ajh.20963] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
43 Mann KG. Analyses of protein S function. Blood 2005;106:1884; author reply 1884-5. [PMID: 16113232 DOI: 10.1182/blood-2004-12-4706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
44 Marchetti G, Caruso P, Lunghi B, Pinotti M, Lapecorella M, Napolitano M, Canella A, Mariani G, Bernardi F. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J Thromb Haemost 2008;6:797-803. [PMID: 18315553 DOI: 10.1111/j.1538-7836.2008.02934.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
45 Rosing J, Maurissen L, Tchaikovski S, Tans G, Hackeng T. Protein S is a cofactor for tissue factor pathway inhibitor. Thrombosis Research 2008;122:S60-3. [DOI: 10.1016/s0049-3848(08)70021-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
46 Castoldi E, Simioni P, Tormene D, Rosing J, Hackeng TM. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. Journal of Thrombosis and Haemostasis 2010;8:294-300. [DOI: 10.1111/j.1538-7836.2009.03712.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
47 Kukla M, Waluga M, Żorniak M, Berdowska A, Wosiewicz P, Sawczyn T, Bułdak RJ, Ochman M, Ziora K, Krzemiński T, Hartleb M. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World J Gastroenterol 2017;23:2613-24. [PMID: 28465646 DOI: 10.3748/wjg.v23.i14.2613] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
48 Baroni M, Mazzola G, Kaabache T, Borgel D, Gandrille S, D'angelo SV, Marchetti G, Di Iasio MG, Pinotti M, D'angelo A, Bernardi F. Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function: Type II mutation in PS-EGF4 domain. Journal of Thrombosis and Haemostasis 2006;4:186-91. [DOI: 10.1111/j.1538-7836.2005.01682.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
49 Heeb MJ, Schuck P, Xu X. Protein S multimers and monomers each have direct anticoagulant activity. J Thromb Haemost 2006;4:385-91. [DOI: 10.1111/j.1538-7836.2006.01743.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]